Home biotech
 

Keywords :   


Tag: biotech

BBP: A Specialized Biotech ETF With Excellent Potential

2015-06-16 15:51:48| Biotech - Topix.net

There are biotech ETFs on the market, but they are relatively few, with offerings by State Street / SPDR , BlackRock / iShares , Van Eck / Market Vectors and others. On 16 December 2014, the ETF market saw the addition of two more biotechnology ETFs, one of which - BioShares Biotechnology Products ETF - will be the topic of this analysis.1 BBP is offered by LifeSci Index Partners under its BioShares banner and is structured so as to consist of only those biotechnology companies that have actual products on the market.

Tags: excellent potential specialized biotech

 

Biotech Stocks Not Expensive Despite Long Bull Run

2015-06-15 22:09:25| Biotech - Topix.net

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 9+ You may proceed to the site by clicking here , however some pages might not work correctly.

Tags: long run expensive stocks

 
 

Nivalis Therapeutics A No-Brainer For Biotech Investors

2015-06-15 22:09:24| Biotech - Topix.net

Nivalis Therapeutics is a mid-clinical trial stage pharmaceutical company working with therapies that target certain gene mutations in cystic fibrosis patients. The company is preparing for its initial public offering to raise funds for continuing clinical trials and research.

Tags: investors biotech therapeutics nobrainer

 

Two SD Biotech Companies To Be Recognized Nationally

2015-06-15 19:02:11| Biotech - Topix.net

Two South Dakota companies will be recognized this week at a national bioscience convention. The BIO International convention to promote the biotechnology industry is held in Philadelphia this week.

Tags: companies recognized nationally biotech

 

Breaking down the biotech compensation boom

2015-06-15 14:53:30| Biotech - Topix.net

Roughly a month after it was reported that Vertex Pharmacetucials CEO Jeff Leiden received compensation in 2014 that included a $1.1 million salary, $14.9 million in value from a one-time restricted stock grant and $22.9 million in stock awards and bonuses, the pay parade has continued for senior executives at other major biotech and life sciences companies.

Tags: compensation breaking boom biotech

 

Sites : [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] next »